Action LLY ELI LILLY AND COMPANY
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Eli Lilly and Company NEO Exchange

Actions

LLY

CA28655A1066

Cours en clôture NEO Exchange
Autres places de cotation
 00:00:00 03/07/2024 		Varia. 5j. Varia. 1 janv.
33,37 CAD -2,26% Graphique intraday de Eli Lilly and Company -1,53% +51,41%
03/07 Les valeurs à surveiller alors que Biden et Trump s'affrontent pour la présidence RE
03/07 Les actions sont en légère hausse avant la cloche, dans l'attente de plusieurs rapports économiques clés ; l'Asie et l'Europe sont en hausse. MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024
AQ
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases
AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round
AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
PR
Lilly Declares Third-Quarter 2024 Dividend
PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products
PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®
PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks
PR
Lilly announces departure of Anat Ashkenazi, chief financial officer
PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality
AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
AQ
Eli Lilly and : Asco Lilly Oncology Presentation
PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER
AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
PR
Major manufacturing investment to support API production for tirzepatide
AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
AQ
Eli Lilly and : 2015 Global Health Programs Report
PU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action LLY
  4. Action LLY
  5. Actualités Eli Lilly and Company
  6. Communiqués